2‐Phenylquinolines Exhibit Anti‐Severe Acute Respiratory Syndrome Coronavirus‐2 Activity Through the Nonstructural Protein 13 Helicase Inhibition
ChemMedChem · 2026
DOI: 10.1002/cmdc.202501063 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Giada Cernicchi und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Quinolines, Viral Nonstructural Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU-MUR PNRR, PRIN 2022, Hercules Foundation.
Abstract (Originalsprache)
The Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) pandemic has highlighted the fragility of our therapeutic arsenal against human coronaviruses and the urgent need to develop new antivirals. They should exhibit broad‐spectrum activity to address future pandemics and target alternative viral proteins to mitigate resistance. We have previously identified a hit compound based on a 2‐phenylquinoline scaffold that is able to hinder SARS‐CoV‐2 replication through nonstructural protein 13 (nsp13) helicase inhibition. Here we reported a SAR study that led to identify new analogs such as 2‐(4‐butoxyphenyl)‐4‐[2‐(6,7‐dimethoxy‐3,4‐dihydroisoquinolin‐2(1H)‐yl)ethoxy]−5,7‐dimethoxyquinoline ( 14 ) and 4‐[2‐(6,7‐dimethoxy‐3,4‐dihydroisoquinolin‐2(1H)‐yl)ethoxy]‐2‐(4‐isopropoxyphenyl)−5,7‐dimethoxyquinoline ( 15 ), which exhibited a good antiviral profile (EC 50 = 8.06 and 9.11 µM) coupled with a low micromolar inhibition of nsp13 helicase. Time‐of‐addition assays and binding analyses confirmed helicase as their primary target, while kinetic studies revealed ATP‐competitive inhibition. The butoxy derivative 14 also inhibited HCoV‐229E and HCoV‐OC43 replication, indicating broad‐spectrum potential. The safety of the compounds was validated in bronchial epithelium cells BEAS‐2B cells and H9c2 cardiac cells, where they did not affect cell viability or reactive oxygen species (ROS) production. Finally, preliminary ADME studies on 15 showed a positive profile in terms of membrane permeability and metabolic stability in plasma and human liver microsomes. This SAR study, along with mechanistic exploration, paves the way for further optimization of 2‐phenylquinoline‐based compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
- Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, Cagliari, Italy.
- KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Molecular Genetics and Therapeutics in Virology and Oncology Research Group, Leuven, Belgium.
- KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium.
- Department of Health Sciences, University of "Magna Græcia" of Catanzaro, Catanzaro, Italy.
- Department of Pharmacy, University of Salerno, Fisciano, Italy.
ORCID-Profile: Steven De Jonghe, Oriana Tabarrini
Förderung
- NextGenerationEU-MUR PNRR
- PRIN 2022
- Hercules Foundation
Zitieren
APA
Cernicchi, G., Nizi, M. G., Emmolo, R., Persoons, L., Laporte, M., Jochmans, D., Romeo, I., Pepe, G., Milite, C., Campiglia, P., Spezzini, J., Martelli, A., Brogi, S., Esposito, F., Felicetti, T., Massari, S., Manfroni, G., Sabatini, S., Sbardella, G., …, & Tabarrini, O. (2026). 2‐Phenylquinolines Exhibit Anti‐Severe Acute Respiratory Syndrome Coronavirus‐2 Activity Through the Nonstructural Protein 13 Helicase Inhibition. ChemMedChem. https://doi.org/10.1002/cmdc.202501063
Vancouver
Cernicchi G, Nizi MG, Emmolo R, Persoons L, Laporte M, Jochmans D, et al. 2‐Phenylquinolines Exhibit Anti‐Severe Acute Respiratory Syndrome Coronavirus‐2 Activity Through the Nonstructural Protein 13 Helicase Inhibition. ChemMedChem. 2026. doi:10.1002/cmdc.202501063
BibTeX
@article{Cernicchi2026,
author = {Cernicchi, Giada and Nizi, Maria Giulia and Emmolo, Roberta and Persoons, Leentje and Laporte, Manon and Jochmans, Dirk and Romeo, Isabella and Pepe, Giacomo and Milite, Ciro and Campiglia, Pietro and Spezzini, Jacopo and Martelli, Alma and Brogi, Simone and Esposito, Francesca and Felicetti, Tommaso and Massari, Serena and Manfroni, Giuseppe and Sabatini, Stefano and Sbardella, Gianluca and Alcaro, Stefano and Neyts, Johan and Corona, Angela and Tramontano, Enzo and De Jonghe, Steven and Tabarrini, Oriana},
title = {2‐Phenylquinolines Exhibit Anti‐Severe Acute Respiratory Syndrome Coronavirus‐2 Activity Through the Nonstructural Protein 13 Helicase Inhibition},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.202501063}
}
EUVIMED